Colorado-based medical device maker Spectranetics (NSDQ:SPNC) broke out the red ink in 2013, blaming the swing partly on the newly implemented medtech excise tax, which requires that companies pay a 2.3% levy on all U.S. sales of applicable medical devices.
WALTHAM, Mass.--(BUSINESS WIRE)--Apr 24, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), announced that it had entered into an agreement with Omron Healthcare Co., Ltd. to be the exclusive distributor for NC-stat ®...
Texas Institute for Robotic Surgery Among First in Nation To Perform Single-Site Robotic Hysterectomy SurgeryApril 24, 2013 10:53 am | by PR Newswire | Comments
AUSTIN, Texas, April 24, 2013 /PRNewswire/ -- The Texas Institute for Robotic Surgery at St. David's North Austin Medical Center recently became one of the first facilities in the nation to perform a hysterectomy using a new single-site platform for robotic surgery.
Z-Medica Announces Expanded CE Indications for QuikClot Hemostatic Dressings Supporting Broader Use in Surgical Wound CareApril 24, 2013 10:07 am | by PR Newswire | Comments
WALLINGFORD, Conn., April 24, 2013 /PRNewswire/ -- Z-Medica®, a leading developer and marketer of hemostatic agents, announced newly expanded CE indications for QuikClot® Hemostatic Dressings today. The expanded indications support the use of QuikClot® products as an...
Improvised explosive devices (IEDs) are becoming a global problem for the U.S. armed forces. To prevent injuries to soldiers and provide better care to those who are injured, the U.S. military is striving to better understand how blasts impact the human body.
Picomole has announced that it has developed a diagnostic test to detect lung cancer that has a preliminary accuracy of 98.5%. This best-in-class result is better than any other technique currently in use for the detection of lung cancer, according to the company.
As leaders across business, policy and academia gathered at the recent World Health Care Congress (WHCC) to discuss ways to improve the quality and cost of healthcare, experts in treatment adherence identified a common theme: a patient-centric adherence strategy will be critical to achieving success.
This is a brief overview of information related to FDA’s approval to market this product. See the links to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval.
At this week’s Biotechnology Industry Organization show in Chicago, a panel of law experts bemoaned the recent Supreme Court hearings on whether individual genes can be patented, saying there was no sign that anyone involved in the case truly understood the technology or the business implications of their arguments.
Millstone Medical Outsourcing announced today that the company will offer customers an expanded medical device distribution service, which includes the ability to distribute directly to patients and to provide wholesale distribution to distributors, hospitals, and sales representatives.
By using swarms of untethered grippers, each as small as a speck of dust, Johns Hopkins engineers and physicians say they have devised a new way to perform biopsies that could provide a more effective way to access narrow conduits in the body as well as find early signs of cancer or other diseases.
Sen. Max Baucus (D-Mont.) is reportedly planning to retire when his current term ends this year, according to multiple news outlets today, potentially removing a key opponent to the medical device industry's push to repeal a 2.3% tax on U.S. medtech sales.
Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with nonobese men and were at a greater risk for subsequently developing prostate cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Interrad Medical Announces Excellent SecurAcath Clinical Study Results in Two New Publications Which Highlight Patient and Cost-Effectiveness BenefitsApril 23, 2013 12:56 pm | by The Associated Press | Comments
Interrad Medical, Inc. a privately held medical device company, announced today the publication of clinical study data for the SecurAcath catheter securement device in the Journal of Infusion Nursing, May/June 2013 issue and the Canadian Journal of Anesthesia May 2013 issue.
Mauna Kea Technologies Announces Highlights of 5th Annual International Conference of Cellvizio(R) Users (ICCU)April 23, 2013 11:45 am | by The Associated Press | Comments
Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced highlights from the 5th Annual International Conference of Cellvizio Users (ICCU) held in Versailles, France, from April 5 to 7. Over 200...